Depressive disorders, bipolar disorder and related disorders, anxiety disorders, obsessive-compulsive disorder and related disorders, trauma and stress-related disorders
Conditions
Interventions
None listed
Sponsors
PreMedica Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: [Mental disorder group] Patients who have been diagnosed with depression, bipolar disorder and related disorders, anxiety disorder, obsessive-compulsive disorder and related disorders, or trauma and stress-related disorders in the DSM-5-TR. The presence or absence of other psychiatric disorders is not an issue. In addition, only patients who are willing to submit a urine sample for biopyrrin testing within 7 days of starting treatment for a psychiatric disorder, including at other hospitals, are eligible. [Healthy group] Patients who have never been diagnosed with a psychiatric disorder, whose interview results at the time of registration are below the standard value (PHQ-9 < 10 points, GAD-7 < 10 points), and who have not self-reported abnormal findings in a health check within the past year prior to registration.
Exclusion criteria
Exclusion criteria: 1. Those with a history of cardiovascular or neurological disease 2. Those with a confirmed drug or alcohol dependency 3. Those who are pregnant or within one month of giving birth 4. Those currently diagnosed with kidney disease, liver cirrhosis, or malignant neoplasms 5. Others who are deemed inappropriate by a doctor at the study cooperating institution
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differences in biopyrrin levels in psychiatric disorders compared to healthy controls | — |
Countries
Japan
Contacts
Public ContactShozo Sato
PreMedica Inc. Business Development Department
Outcome results
None listed